RVPH
Price
$0.29
Change
-$0.00 (-0.00%)
Updated
Sep 26, 01:25 PM (EDT)
Capitalization
28.42M
52 days until earnings call
VACBF
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Sep 17 closing price
Capitalization
54.56M
Interact to see
Advertisement

RVPH vs VACBF

Header iconRVPH vs VACBF Comparison
Open Charts RVPH vs VACBFBanner chart's image
Reviva Pharmaceuticals Holdings
Price$0.29
Change-$0.00 (-0.00%)
Volume$100
Capitalization28.42M
NYKODE THERAPEUTICS AS
Price$0.20
Change-$0.01 (-4.76%)
Volume$10K
Capitalization54.56M
RVPH vs VACBF Comparison Chart in %
Loading...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RVPH vs. VACBF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RVPH is a Buy and VACBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (RVPH: $0.29 vs. VACBF: $0.20)
Brand notoriety: RVPH and VACBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RVPH: 103% vs. VACBF: 154%
Market capitalization -- RVPH: $28.42M vs. VACBF: $54.56M
RVPH [@Biotechnology] is valued at $28.42M. VACBF’s [@Biotechnology] market capitalization is $54.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RVPH’s FA Score shows that 1 FA rating(s) are green whileVACBF’s FA Score has 1 green FA rating(s).

  • RVPH’s FA Score: 1 green, 4 red.
  • VACBF’s FA Score: 1 green, 4 red.
According to our system of comparison, both RVPH and VACBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RVPH’s TA Score shows that 4 TA indicator(s) are bullish while VACBF’s TA Score has 0 bullish TA indicator(s).

  • RVPH’s TA Score: 4 bullish, 6 bearish.
  • VACBF’s TA Score: 0 bullish, 3 bearish.
According to our system of comparison, both RVPH and VACBF are a bad buy in the short-term.

Price Growth

RVPH (@Biotechnology) experienced а -29.66% price change this week, while VACBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

RVPH is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VACBF($54.6M) has a higher market cap than RVPH($28.4M). VACBF YTD gains are higher at: -16.944 vs. RVPH (-83.702). VACBF has higher annual earnings (EBITDA): -21.96M vs. RVPH (-27.07M). VACBF has more cash in the bank: 70M vs. RVPH (10.4M). RVPH has less debt than VACBF: RVPH (113K) vs VACBF (3.1M). VACBF has higher revenues than RVPH: VACBF (7.31M) vs RVPH (0).
RVPHVACBFRVPH / VACBF
Capitalization28.4M54.6M52%
EBITDA-27.07M-21.96M123%
Gain YTD-83.702-16.944494%
P/E RatioN/AN/A-
Revenue07.31M-
Total Cash10.4M70M15%
Total Debt113K3.1M4%
FUNDAMENTALS RATINGS
RVPH: Fundamental Ratings
RVPH
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
11
SEASONALITY SCORE
1..100
17

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RVPHVACBF
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
67%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
45%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
38%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
13%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
37%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDXG0.890.07
+9.09%
Interpace Biosciences, Inc.
NPACY1.05N/A
N/A
Quadient SA
BDVSF14.05N/A
N/A
Bidvest Group Ltd.
DCMDF1.00-0.02
-2.06%
Data Communications Management Corp.
TTNDF11.56-0.74
-6.02%
Techtronic Industries Ltd.

RVPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVPH has been loosely correlated with ALT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RVPH jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
+0.24%
ALT - RVPH
50%
Loosely correlated
N/A
INDP - RVPH
30%
Poorly correlated
+10.81%
GYRE - RVPH
30%
Poorly correlated
-1.09%
INM - RVPH
29%
Poorly correlated
N/A
ARCT - RVPH
25%
Poorly correlated
-0.68%
More

VACBF and

Correlation & Price change

A.I.dvisor tells us that VACBF and HYPD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VACBF and HYPD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VACBF
1D Price
Change %
VACBF100%
N/A
HYPD - VACBF
32%
Poorly correlated
-11.97%
SPHRY - VACBF
27%
Poorly correlated
+3.57%
RVPH - VACBF
22%
Poorly correlated
+0.24%
ZBIO - VACBF
21%
Poorly correlated
-8.19%
BPTSY - VACBF
20%
Poorly correlated
N/A
More